Biotheus Inc. (Biotheus), a clinical-stage biotech company focusing on the discovery and development of biologics …
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention …
CDR-Life Announces FDA Clearance of IND Application for CDR404 for Treatment of Solid Tumors
CDR-Life Inc. today announced the clearance of an Investigational New Drug (IND) application with the U.S. …
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology
MediLink Therapeutics (“MediLink”), announced today that it has entered into a worldwide collaboration and license …
Johnson & Johnson Submits Supplemental Biologics License Application and New Drug Application to U.S. FDA Seeking Approval of RYBREVANT® (amivantamab-vmjw) Plus Lazertinib for the Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to …
Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer Immunotherapy
On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their …
Glenmark’s new drug candidate to undergo first-in-human trial for treatment of advanced solid tumors and lymphomas
Glenmark Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) to begin …
